GENF — Genflow Biosciences Share News
0.000.00%
Genflow Biosciences - Presentation of Interim Results
Genflow Biosciences - Exercise of Warrants and Issue of Equity
Genflow Biosciences - Half-year Financial Report
Brief: Genflow Biosciences Says Slab Clinical Trial Meets Primary Endpoint
Genflow Biosciences - Primary Endpoint in SLAB Clinical Trial Met
RCS - Genflow Biosciences - Appointment of Investor Relations Adviser
Genflow Biosciences - Patent Update
RCS - Genflow Biosciences - Mid-Year Operational and Corporate Summary
RCS - Genflow Biosciences - Participation at BIO International Convention 2026
Genflow Biosciences - Notice of AGM
Genflow Biosciences - Exercise of Warrants and Issue of Equity
Genflow Biosciences - Final Results
Brief: Genflow Biosciences Expands Engagement With Global Animal Health Sector
Genflow Biosciences - Expansion of Confidentiality Agreements
RCS - Genflow Biosciences - Strategic Technology Collaboration
RCS - Genflow Biosciences - Update on the Dog Study
Genflow Biosciences - Issue of Equity & PDMR Notifications
Genflow Biosciences - Notice of GM
Genflow Biosciences - Holding(s) in Company